Navigation Links
Central Florida Pain Relief Expert Dr. Avi Bhandary Gives Patients Their Life Back with BOTOX®
Date:5/29/2013

Orlando, FL (PRWEB) May 29, 2013

Dr. Avi Bhandary of Rehabilitation Medical Group, a leading comprehensive pain management practice in Central Florida, is giving patients their life back through the FDA-approved use of BOTOX® (Botulinum toxin A) as a preventative treatment for chronic migraines.

Sharon and Meghan McGinnis have suffered from chronic migraines for most of their lives. The mother and daughter said they have tried nearly everything for relief, but only one thing has worked for them – BOTOX®. “This finally gave us our life back,” Meghan McGinnis said. “We’ve been telling anybody that has migraines, ‘You’ve got to go try this.’”

The Food and Drug Administration approved BOTOX® injections for migraine treatment in 2010, after clinical studies funded by Allergan, Inc. produced evidence that patients showed improvement in incidence of chronic migraines for migraine sufferers receiving the BOTOX® treatment. Several trials since have shown Botulinum toxin A improves headache symptoms and quality of life when used as a preventative treatment for migraines.

“When you can promise a patient who has suffered with chronic migraines headache-free days, that's something that means a lot to them,” Bhandary said. Patients suffering from chronic migraines experience symptoms including light-sensitivity, nausea and vomiting, blurred vision or vision loss, and pulsating or throbbing pain. For some patients these symptoms, and the chronic nature of their migraines, are so severe that daily activities such as working become difficult, if not impossible.

Migraine treatment options include pain-relieving prescription medications from Triptans such as Imitrex®, to anti-nausea medications and opiates. These medications are designed to treat the symptoms of migraines, and though effective, often come with side effects that pose problems for patients longer-term. “BOTOX relaxes the muscles and reduces contractions, stopping migraines before they start,” Dr. Bhandary said. “For some patients, this is a quality of life they never knew was possible.”

For migraine patient Meghan McGinnis, “This is different - this is what normal feels like.” Dr. Bhandary’s insight, clinical skill, and knowledge of the use of Botulinum toxin A for the therapeutic treatment of chronic migraines, is giving migraine patients in Central Florida new hope.

About Dr. Bhandary:
Dr. Avi Bhandary is an award-winning physician who joined Dr. Michael Creamer, one of Orlando’s most experienced interventional physicians, at Rehabilitation Medical Group (RMG) in 2012. Dr. Bhandary’s extensive experience with Botulinum toxin A is a result of his training at the University of Pittsburgh, working with stroke related spasticity and children afflicted with Cerebral Palsy. Patients can see Dr. Bhandary at Rehabilitation Medical Group to evaluate headache symptoms, assess and potentially rule out possible underlying factors such as cervical spine disorders, and receive expert opinion on the safety and efficacy of Botulinum toxin A for the treatment of migraines and spasticity. Rehabilitation Medical Group physicians hold certifications in the field of Pain Medicine, as well as Physical Medicine and Rehabilitation. RMG provides patients in Central Florida with customized care plans that emphasize independence, comfort and the maintenance of functionality, working to eliminate over-dependence on prescription pain medications.

Read the full story at http://www.prweb.com/releases/BotoxForMigraines/BhandaryRMGOrlando/prweb10768590.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. KORT's Athletic Training Program at Central High School Sends Student to National Health Sciences Competition
2. Preferred retinal location may aid rehabilitation in patients with central vision loss
3. Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements
4. Hound.com Finds Jobs in South Atlantic and South West Central Regions Mirroring Current Employment Trends
5. Central Oregon Management Consultant Earns TIGERS Success Series Team Development and Team Effectiveness Certification and Licensing
6. Central Marketplace, Inc. Launches Website Featuring AllerAir Air Purifiers
7. Study finds key protein for firing up central nervous system inflammation
8. Online Birkenstock Store BirkenstockCentral.com is offering Life is good® Limited Edition Boston Love Tee Shirt
9. Mom Central Bloggers to Get a Sneak Peak at the New and Improved Adult Essentials Multi Vitamin Gummies
10. Medistra Hospital, Jakarta Becomes First Hospital in Indonesia with Centralized Image Archive
11. WINFertility Treatment Program Expands to Central/Southern Texas. Program Makes IVF Treatment More Affordable for Patients Without Infertility Insurance Coverage.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Kennett Square, PA (PRWEB) , ... March 23, 2017 , ... ... sunny days. That means many students are thinking about summer internships , which ... (or lack thereof). , The pros at Garden Media Group, a boutique public relations ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... products at competitive pricing. Verisys through its FACIS and other ... restrictions and Disciplinary actions. , “We are delighted to be able to offer ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... stands with all Americans facing life-altering and fatal diseases in opposition to the ... shortsighted decisions that would eviscerate care, services, and hope for the most vulnerable ...
(Date:3/23/2017)... ... March 23, 2017 , ... On ... Dagger Foundation the US Special Operations Command’s Patriot Award. The award was presented ... thanked Task Force Dagger Foundation for its significant and enduring support to the ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The Boulevard ... 10am - 2pm. All events will be located in the Main West Entrance ... a no-cost Child ID event. No appointment is necessary and each child with a ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Md. , March 23, 2017  The U.S. ... Bavencio (avelumab) for the treatment of adults and pediatric ... carcinoma (MCC), including those who have not received prior ... MCC, a rare, aggressive form of skin cancer. ... common cancers, patients with a rare form called Merkel ...
(Date:3/23/2017)... VANCOUVER, British Columbia , March 23, ... ) (the "Company" or "Sophiris"), a clinical late-stage biopharmaceutical ... diseases, today announced that data from its successful Phase ... a focal treatment for localized prostate cancer, will be ... the 32 nd Annual European Association of Urology ...
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... their offering. ... The global oxygen therapy devices market to grow at a CAGR ... Global Oxygen Therapy Devices Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Medicine Technology: